✂️ SPLITS & UPLISTINGS TODAY · Tue Oct 20 ✂️ $MBRX 1-for-20 reverse split ✂️ $REVB 1-for-7 reverse split

📊 TODAY'S DILUTION · Mon Oct 19 🔴 $RUBI $15.0M converts at $0.3646 or 85% VWAP 🔁 $GOAI $10.0M equity line at $2.00/share fixed 📝 $HOST 45.4M shares resale (~161% of shares outstanding) 📄 $AIAI S-1 filed 4 sub-$300M filings tracked by Signal8 today.

📝 RESALE REGISTERED $GRDX · GridAI Technologies Technology · Nano cap ($31.3M) Shares: up to 9.9M (~139% of 7.1M shares outstanding) Pre-funded warrants: 4.7M at $0.00001 Common warrants: 5.0M underlying Cash: $1.4M vs $7.8M annual burn Going concern: disclosed 424B3 registers up to 9.91mln shares for resale by selling stockholders from May and July 2026 private placements; company will not receive proceeds from resales but is dependent on $12.3M in remaining placement proceeds contingent on registration effectiveness by Jan 2027.

🗳️ SHARE INCREASE VOTE $MDCX · Medicus Pharma Healthcare · Nano cap ($3.81M) Blank cheque preferred: unlimited Class A (board sets series terms, no further shareholder vote) Forward split: up to 50:1 (would reverse the 1-for-50 consolidation done Oct 12, 2026) Shares outstanding: 1.9M (as of Oct 16, 2026) Officers/directors: 14.4% (CEO 5.3%) Meeting: Dec 2, 2026 PRE 14A: special meeting asks shareholders to authorize unlimited blank cheque preferred shares and a forward split of up to 50:1; company warns a near-maximum split could push per-share price back below the $1.00 Nasdaq minimum.

🗳️ REVERSE SPLIT VOTE $VVOS · Vivos Therapeutics Healthcare · Nano cap ($4.53M) Ratio: 1-for-20 to 1-for-40 (board discretion) Nasdaq notice: Jun 5, 2026 (bid-price deficiency); deadline Dec 2, 2026 Dilution pending vote: up to 18.5M shares (Seneca Series A) + up to 80.0M shares (SOD Sciences Series C) Shares outstanding: 33.6M Equity plan: +4.9M shares proposed Going concern: disclosed PRE 14A: shareholders vote Nov 18 on a reverse split to regain Nasdaq bid-price compliance; company notes the split does not cure a separate stockholders' equity deficiency (Rule 5550(b)(1)).

🔒 PRIVATE PLACEMENT $CNTM · ConnectM Technology Solutions Technology · Nano cap ($28.1M) Raise: $1.25M net (~4% of market cap), final tranche Converts: $1.39M principal at $4.5885 or 95% of lowest 5-day VWAP (default only), floor $1.00 Interest: 10.0% (1yr guaranteed) / 24.0% on default Aggregate issued to Ascent Partners: ~$5.0M Ownership cap: 9.99% 8-K Items 1.01/2.03/3.02: final closing Oct 13 on a senior secured convertible note to Ascent Partners Fund LLC; amortization begins no later than Feb 28, 2027, payable in stock if equity conditions are met.

🔁 EQUITY LINE $GOAI · Eva Live Technology · Micro cap ($60.1M) Capacity: up to $10.0M at $2.00/share fixed (36 months) Shares: 5.0M put shares + 275.0K warrant at $0.01, 5yr Dilution: ~13% of 40.5M shares outstanding Put price: $2.00 vs $1.55 prior close (+29% above market) Going concern: disclosed 424B5 registers up to 5.275M shares for resale by Hudson Global Ventures under a Sept 17, 2026 equity purchase agreement; company may draw up to $10.0M in puts over 36 months.

🔒 PRIVATE PLACEMENT $GCTK · GlucoTrack Healthcare · Nano cap ($1.62M) Warrants: 406,198 at $7.50, 5yr (full-ratchet anti-dilution, floor 20% of issuance-date price) Ownership cap: 9.99% Approval: Nasdaq Rule 5635 stockholder vote required before exercisable 8-K Items 1.01/3.02: new warrants issued Oct 13 to existing warrant holders under a Waiver Agreement that removes the equity issuance lock and variable-rate-transaction price ratchet from the July 2026 Securities Purchase Agreement.

🗳️ SHARE INCREASE VOTE $MWYN · Marwynn Holdings Technology · Nano cap ($47.7M) Authorised: 500.0M -> 2.0B common shares (4x) Super-voting preferred: 135,000 -> 700,000 Series A (1,000 votes/share, issuable to CEO) CEO voting power: ~90.85% currently; ~98.03% if all new preferred issued to her Shares outstanding: 20.2M PRE 14A: 2026 Annual Meeting (record date Oct 29) asks shareholders to approve a 4x authorized common increase and a 5x expansion of Series A super-voting preferred, with new shares issuable to CEO Yin Yan to preserve control after any reverse split or dilutive financing.

🔒 PRIVATE PLACEMENT $RUBI · Rubico Industrials · Nano cap ($1.33M) Converts: $9.44M initial notes at $0.3646 fixed or 85% of lowest 10-day VWAP (floor $0.10) Raise: $8.5M gross (~639% of market cap), 12-month maturity Interest: 8.0% cash / 10.0% in shares / 18.0% on default Warrants: $9.44M at $0.3646, 5yr + 5% commitment shares Agent: Maxim Group LLC, 6.0% fee 6-K: initial closing Oct 19 on $9.44M of senior convertible notes and warrants; second tranche of $5.56M contingent on share price >= $1.00 and $200K avg daily dollar volume; purchaser holds 50% participation right in future offerings.

🔴 OFFERING PRICED $RUBI · Rubico Industrials · Nano cap ($1.50M) Raise: $13.5M gross, $8.5M first tranche (900% of market cap) Converts: $15.0M notes at $0.3646 fixed or 85% of lowest 10-day VWAP, floor $0.10 Interest: 8.0% cash / 10.0% in shares, 10.0% OID, 12-month maturity Warrants: up to $15.0M exercise capacity at $0.3646, 5yr Agent: Maxim Group, 6.0% fee 424B5: $15.0M senior convertible notes to one institutional investor in two tranches off its S-3 shelf; first tranche closes on or about Oct 19, 2026.

🗳️ REVERSE SPLIT VOTE $CODX · Co-Diagnostics Healthcare · Nano cap ($5.12M) Ratio: 1-for-2 to cumulative 1-for-750 (board discretion, 12 months) Prior split: 1-for-30 (Dec 2025) Converts: $3.1M notes at 90% of lowest 10-day VWAP, floor resets every 6 months Commitment shares: 600.0K + 3.4M warrants at $1.56 Shares outstanding: 8.1M (fully diluted: 16.1M) Equity plan: +2.0M shares proposed PRE 14A: court-ordered special meeting (quorum reduced to 33 1/3%) to approve a reverse split up to cumulative 1-for-750, J.J. Astor convertible note conversion, and a 2.0M-share equity plan increase.